These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33750099)

  • 21. Catabolism of antibody drug conjugates and characterization methods.
    Shadid M; Bowlin S; Bolleddula J
    Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
    Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
    Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
    Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
    Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single liquid chromatography-quadrupole time-of-flight mass spectrometric method for the quantification of total antibody, antibody-conjugated drug and free payload of antibody-drug conjugates.
    Byeon JJ; Park MH; Shin SH; Lee BI; Park Y; Choi J; Kim N; Kang Y; Shin YG
    Biomed Chromatogr; 2018 Jul; 32(7):e4229. PubMed ID: 29505175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
    Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
    Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
    Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
    J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugation Site Influences Antibody-Conjugated Drug PK Assays: Case Studies for Disulfide-Linked, Self-Immolating Next-Generation Antibody Drug Conjugates.
    Lee MV; Kaur S; Saad OM
    Anal Chem; 2020 Sep; 92(18):12168-12175. PubMed ID: 32786429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.
    Matsuda Y; Robles V; Malinao MC; Song J; Mendelsohn BA
    Anal Chem; 2019 Oct; 91(20):12724-12732. PubMed ID: 31478640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enabling the formation of native mAb, Fab' and Fc-conjugates using a bis-disulfide bridging reagent to achieve tunable payload-to-antibody ratios (PARs).
    Thoreau F; Rochet LNC; Baker JR; Chudasama V
    Chem Sci; 2023 Apr; 14(14):3752-3762. PubMed ID: 37035695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC-HRMS quantitation of intact antibody drug conjugate trastuzumab emtansine from rat plasma.
    Jin W; Burton L; Moore I
    Bioanalysis; 2018 Jun; 10(11):851-862. PubMed ID: 29863890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis.
    Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G
    J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LC/MS/MS Bioanalysis of Protein-Drug Conjugates-The Importance of Incorporating Succinimide Hydrolysis Products.
    Shi C; Goldberg S; Lin T; Dudkin V; Widdison W; Harris L; Wilhelm S; Jmeian Y; Davis D; O'Neil K; Weng N; Jian W
    Anal Chem; 2018 Apr; 90(8):5314-5321. PubMed ID: 29589741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridged Cysteine Conjugations.
    Bird M; Nunes J; Frigerio M
    Methods Mol Biol; 2020; 2078():113-129. PubMed ID: 31643053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.
    Sun X; Ponte JF; Yoder NC; Laleau R; Coccia J; Lanieri L; Qiu Q; Wu R; Hong E; Bogalhas M; Wang L; Dong L; Setiady Y; Maloney EK; Ab O; Zhang X; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2017 May; 28(5):1371-1381. PubMed ID: 28388844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly.
    Farràs M; Miret J; Camps M; Román R; Martínez Ó; Pujol X; Erb S; Ehkirch A; Cianferani S; Casablancas A; Cairó JJ
    MAbs; 2020; 12(1):1702262. PubMed ID: 31876436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis.
    Janin-Bussat MC; Dillenbourg M; Corvaia N; Beck A; Klinguer-Hamour C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():9-13. PubMed ID: 25596378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions.
    Bahou C; Love EA; Leonard S; Spears RJ; Maruani A; Armour K; Baker JR; Chudasama V
    Bioconjug Chem; 2019 Apr; 30(4):1048-1054. PubMed ID: 30855134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfide re-bridging reagents for single-payload antibody-drug conjugates.
    King TA; Walsh SJ; Kapun M; Wharton T; Krajcovicova S; Glossop MS; Spring DR
    Chem Commun (Camb); 2023 Aug; 59(65):9868-9871. PubMed ID: 37492000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural characterization of antibody drug conjugate by a combination of intact, middle-up and bottom-up techniques using sheathless capillary electrophoresis - Tandem mass spectrometry as nanoESI infusion platform and separation method.
    Said N; Gahoual R; Kuhn L; Beck A; François YN; Leize-Wagner E
    Anal Chim Acta; 2016 Apr; 918():50-9. PubMed ID: 27046210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.